Status:

RECRUITING

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients

Lead Sponsor:

Vanderbilt University Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Colorectal Cancer

Esophageal Cancer

Eligibility:

All Genders

18+ years

Brief Summary

RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors ident...

Detailed Description

OBJECTIVES: * Identify new potential biomarkers of increased gastrointestinal cancer risk using tissue and biofluid samples from patients and volunteers undergoing colonoscopy, endoscopy, or surgery....

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Undergoing colonoscopy or endoscopy for diagnostic or screening purposes at the Vanderbilt University Medical Center or at the Veterans Affairs Medical Center AND
  • Meets 1 of the following criteria:
  • Diagnosis of gastrointestinal (GI) cancer, polyps, or inflammatory bowel disease
  • History of previously treated GI cancer, polyps, or inflammatory bowel disease
  • PATIENT CHARACTERISTICS:
  • Capable of giving informed consent
  • Not mentally or medically impaired
  • No bleeding disorder
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

Exclusion

    Key Trial Info

    Start Date :

    June 1 2002

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2045

    Estimated Enrollment :

    5000 Patients enrolled

    Trial Details

    Trial ID

    NCT00899626

    Start Date

    June 1 2002

    End Date

    October 1 2045

    Last Update

    February 10 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Veterans Affairs Medical Center - Nashville

    Nashville, Tennessee, United States, 37212

    2

    Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States, 37232-6838